Results 151 to 160 of about 6,131 (232)

The therapeutic pipeline in migraine: What does the future hold? [PDF]

Neurotherapeutics
Gamal-Eltrabily M, Salinas-Abarca AB, Romero-Reyes M, Akerman S.   +3 more
europepmc   +1 more source

Signal transduction, dimerization, and therapeutic targeting of Orexin and receptor systems. [PDF]

Front Pharmacol
Zhang S, Wang P, Ji B, Shao Y, Hou S, Chen J, Wang C.   +6 more
europepmc   +1 more source

The Role of Danavorexton for Perioperative Opioid-Induced Respiratory Depression and Sedation: A Narrative Review. [PDF]

Clin Pharmacol
Enache AJ, Harris CJ, Atewogbola TI, De Witt AB, Ahmadzadeh S, McGregor Jnr DW, Shekoohi S, Kaye AD.   +7 more
europepmc   +1 more source

Awakening Recovery: Enhancing Orexinergic Tone After Acute CNS Damage. [PDF]

Pharmaceuticals (Basel)
Otero-López P, Madrid-González X, Fernández-Dueñas V, Flores Á.   +3 more
europepmc   +1 more source

Evaluating the safety of orexin receptor antagonists on reproductive health and sexual function. [PDF]

Mol Psychiatry
Hashimoto K.
europepmc   +1 more source

Orexins and Prostate Cancer: State of the Art and Potential Experimental and Therapeutic Perspectives. [PDF]

Cancer Genomics Proteomics, 2023
Costagliola A, Lombardi R, Liguori G, Morrione A, Giordano A.   +4 more
europepmc   +1 more source

Orexin receptor 2 agonists: a pathophysiologic approach to narcolepsy type 1. [PDF]

Ann Med Surg (Lond)
Arif Z, Siddiqui E, Hujjat SFZ, Khan MS, Mauhmoud A.   +4 more
europepmc   +1 more source

Orexine [PDF]

, 2017
openaire   +1 more source

Are orexins-hypocretins the culprit for rapid eye movement sleep behavior disorder in narcolepsy? [PDF]

Sleep
Vanini G.
europepmc   +1 more source

Dissociation of subjective and physiological stress responses in orexin-deficient narcolepsy. [PDF]

Sleep
Zhang Z, Khatami R.
europepmc   +1 more source